The coronavirus epidemic, which spread to the world shortly after it emerged in Wuhan, China, is coming up with new cases and loss of life. Many healthcare providers around the world are working hard to develop drugs to defeat the virus.
The coronavirus epidemic, which has been infecting thousands of people since the first day it was seen and killed more than 28 thousand people worldwide, is growing. Many healthcare providers and scientists have been working on new drugs for days to stop the spread of the virus. A promising statement came from Russia while the eyes of everyone were in the news about the virus.
The drug is finally developed
According to a new statement made today by the Russian Federal Biomedical Agency (FMBA), a drug that could cure coronavirus was eventually developed. This new information, which was described as a good and hopeful development against the virus that swept the world, was received with great interest. In the announcement from the press office affiliated to the agency, it was said that the Russian Federal Biomedical Agency used the medicine Meflokin, previously used against malaria, to treat the coronavirus. According to the information, this new drug based on Meflokin may be effective in coronavirus cases.
The agency said in a detailed statement on the subject, “The Farmzashchita” Research and Production Center of Russia FMBA developed the treatment scheme of coronavirus infection on the basis of Meflokin drug used against malaria, taking into account the experiences of China and France.
Include in treatment guide
It was suggested that the studies be included in the coronavirus treatment guideline of the Ministry of Health of Russia. “The drug blocks the cytopathic effect of the coronavirus in cell cultures with high selectivity and prevents its replication, that is, its replication, the activation of the inflammatory response caused by the virus,” said Veronika Skvortsova, head of the Russian Federal Biomedical Agency. The addition of macrolide antibiotics and synthetic penicillins not only prevents the formation of a secondary bacterial-viral syndrome, but also increases the concentration of antiviral substances in the blood plasma and lungs. This will provide an effective treatment for patients with varying weight of coronavirus infections. ” He brought clarity to the subject with his statements. New developments about the drug are eagerly awaited.